Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiopoietin-related growth factor (AGF) promotes angiogenesis.
Oike Y, Ito Y, Maekawa H, Morisada T, Kubota Y, Akao M, Urano T, Yasunaga K, Suda T. Oike Y, et al. Among authors: akao m. Blood. 2004 May 15;103(10):3760-5. doi: 10.1182/blood-2003-04-1272. Epub 2004 Feb 5. Blood. 2004. PMID: 14764539 Free article.
Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.
Morisada T, Oike Y, Yamada Y, Urano T, Akao M, Kubota Y, Maekawa H, Kimura Y, Ohmura M, Miyamoto T, Nozawa S, Koh GY, Alitalo K, Suda T. Morisada T, et al. Among authors: akao m. Blood. 2005 Jun 15;105(12):4649-56. doi: 10.1182/blood-2004-08-3382. Epub 2005 Feb 10. Blood. 2005. PMID: 15705793 Free article.
Angiopoietin-related growth factor antagonizes obesity and insulin resistance.
Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, Ito Y, Urano T, Kimura Y, Kubota Y, Maekawa H, Miyamoto T, Miyata K, Matsumoto S, Sakai J, Nakagata N, Takeya M, Koseki H, Ogawa Y, Kadowaki T, Suda T. Oike Y, et al. Among authors: akao m. Nat Med. 2005 Apr;11(4):400-8. doi: 10.1038/nm1214. Epub 2005 Mar 20. Nat Med. 2005. PMID: 15778720 Free article.
Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
Urano T, Ito Y, Akao M, Sawa T, Miyata K, Tabata M, Morisada T, Hato T, Yano M, Kadomatsu T, Yasunaga K, Shibata R, Murohara T, Akaike T, Tanihara H, Suda T, Oike Y. Urano T, et al. Among authors: akao m. Arterioscler Thromb Vasc Biol. 2008 May;28(5):827-34. doi: 10.1161/ATVBAHA.107.149674. Epub 2008 Feb 7. Arterioscler Thromb Vasc Biol. 2008. PMID: 18258819
10-Year Trends of Antithrombotic Therapy Status and Clinical Outcomes in Patients With Atrial Fibrillation and Renal Dysfunction　- The Fushimi AF Registry.
Masunaga N, Ishii M, Oka K, Okamoto K, Yoshida Y, Minami K, Ishigami K, Doi K, Hamatani Y, Yoshizawa T, Ide Y, Fujino A, Iguchi M, Wada H, Hasegawa K, Tsuji H, Esato M, Abe M, Akao M; Fushimi AF Registry Investigators. Masunaga N, et al. Among authors: akao m. Circ J. 2024 Oct 31. doi: 10.1253/circj.CJ-24-0614. Online ahead of print. Circ J. 2024. PMID: 39477486 Free article.
479 results